Skip to main content
OpenTrials

Clinical trial condition

EGFR Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Explore clinical trials studying EGFR Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

EGFR Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer trial results

Completed

A Molecular Profiling Study of Patients With EGFR Mutation-positive Locally Advanced or Metastatic NSCLC Treated With Osimertinib

NCT03239340

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Athens, Georgia, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Brescia, Italy
View all 26 locations
View Trial Details

Related conditions